Table 5 Assessment procedure
From: Introduction of organised mammography screening in tyrol: results of a one-year pilot phase
40-49 | 50-59 | 60-69 | Total | |
|---|---|---|---|---|
Additional imaging | ||||
Ultrasound | 140 (100%) | 106 (97.2%) | 61 (92.4%) | 307 (97.5%) |
MRI | 24 (17.1%) | 21 (19.3%) | 21 (31.8%) | 66 (21.0%) |
Biopsy | 63 (45.0%) | 51 (46.8%) | 37 (56.1%) | 151 (47.9%) |
Core biopsy | 51 (36.4%) | 40 (36.7%) | 30 (45.5%) | 121 (38.4%) |
Fine needle biopsy | 10 (7.1%) | 10 (9.2%) | 4 (6.1%) | 24 (7.6%) |
Open biopsy | 2 (1.4%) | 1 (0.9%) | 3 (4.5%) | 6 (1.9%) |
Biopsy rate per 1000 mammograms | 8.8 | 9.0 | 7.7 | 8.6 |
PPV for core biopsy1) | 35.3.4% | 47.5% | 80.0% | 50.4% |
PPV for open biopsy2) | 66.7% | |||
Total | 140 | 109 | 66 | 315 |